Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma

NCT06277050 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

264

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma
High-Risk Cancer
Maintenance Therapy

Interventions

DRUG: Maintenance Therapy with Toripalimab and Capecitabine
DRUG: Maintenance Therapy with Capecitabine

Sponsor

Jiangxi Provincial Cancer Hospital